Ernest Briët
#161,089
Most Influential Person Now
Ernest Briët's AcademicInfluence.com Rankings
Download Badge
Chemistry
Ernest Briët's Degrees
- PhD Pharmaceutical Sciences University of Amsterdam
- Masters Pharmacy University of Groningen
Why Is Ernest Briët Influential?
(Suggest an Edit or Addition)Ernest Briët's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy (1993) (1958)
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study (1993) (1366)
- Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis (1995) (1167)
- Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation (1994) (1125)
- Thromboembolic and Bleeding Complications in Patients With Mechanical Heart Valve Prostheses (1994) (1008)
- Optimal oral anticoagulant therapy in patients with mechanical heart valves. (1995) (944)
- Increased fetal loss in women with heritable thrombophilia (1996) (670)
- Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. (1993) (590)
- Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints (1999) (447)
- Hereditary protein S deficiency: clinical manifestations. (1987) (414)
- Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study) (1995) (388)
- Increased risk of venous thrombosis in carriers of hereditary protein C deficiency defect (1993) (371)
- Factor VII and Fibrinogen Levels as Risk Factors for Venous Thrombosis (1994) (326)
- The Leiden Thrombophilia Study (LETS) (1997) (284)
- A Prospective, Randomized Trial of Prednisone and Cyclophosphamide in the Treatment of Patients with Factor VIII Autoantibodies (1993) (268)
- A sudden increase in factor VIII inhibitor development in multitransfused hemophilia A patients in The Netherlands. Dutch Hemophilia Study Group. (1993) (211)
- Mortality and causes of death in Dutch haemophiliacs, 1973–86 (1989) (204)
- Cardiovascular Determinants of Carotid Artery Disease: The Rotterdam Elderly Study (1992) (202)
- Usefulness of patient interview in bleeding disorders. (1995) (191)
- Assessment of a Bleeding Risk Index in Two Cohorts of Patients Treated with Oral Anticoagulants (1996) (187)
- The spectrum of genetic defects in a panel of 40 Dutch families with symptomatic protein C deficiency type I: heterogeneity and founder effects. (1991) (149)
- Dominant type 1 von Willebrand disease caused by mutated cysteine residues in the D3 domain of von Willebrand factor. (1996) (137)
- Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency. (1999) (133)
- The role of donor antibodies in the pathogenesis of transfusion‐related acute lung injury: a systematic review (2008) (121)
- Hereditary Protein S Deficiency and Venous Thrombo-Embolism (1985) (118)
- Clinical predictors of alloimmunization after red blood cell transfusion (2007) (111)
- Report of a joint WHO/WFH meeting on the control of haemophilia: carrier detection and prenatal diagnosis. (1993) (108)
- Hereditary Protein S Deficiency in Young Adults with Arterial Occlusive Disease (1990) (101)
- Expression of the blood-clotting factor-VIII cDNA is repressed by a transcriptional silencer located in its coding region. (1995) (94)
- Toward Gene Therapy in Haemophilia A: Retrovirus-Mediated Transfer of a Factor VIII Gene into Murine Haematopoietic Progenitor Cells (1992) (85)
- Modern haemophilia treatment: medical improvements and quality of life (1990) (84)
- Optimal intensity of oral anticoagulant therapy after myocardial infarction. (1996) (83)
- Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence. (1994) (80)
- Expression of functional factor VIII in primary human skin fibroblasts after retrovirus-mediated gene transfer. (1990) (79)
- Mortality in hereditary antithrombin-III deficiency—1830 to 1989 (1991) (78)
- Successful treatment with recombinant factor VIIa of therapy‐resistant severe bleeding in a patient with acquired von Willebrand disease (2001) (77)
- Toward gene therapy for hemophilia A: long-term persistence of factor VIII-secreting fibroblasts after transplantation into immunodeficient mice. (1993) (73)
- The putative factor IX gene promoter in hemophilia B Leyden. (1988) (73)
- Physical condition, longevity, and social performance of Dutch haemophiliacs, 1972-85. (1989) (70)
- Fibrinopeptide A and beta thromboglobulin in patients with angina pectoris and acute myocardial infarction. (1984) (70)
- Familial elevation of plasma histidine‐rich glycoprotein in a family with thrombophilia (1987) (68)
- Bleeding complications in oral anticoagulant therapy : an analysis of risk factors (1993) (68)
- Storage time of red blood cells and mortality of transfusion recipients. (2013) (63)
- Carrier testing and prenatal diagnosis for hemophilia: experiences and attitudes of 549 potential and obligate carriers. (1990) (63)
- Prevalence of leucocyte antibodies in the Dutch donor population (2011) (62)
- Hemophilia treatment in historical perspective: a review of medical and social developments (1991) (62)
- Mutations in Severe, Type III von Willebrand’s Disease in the Dutch Population: Candidate Missense and Nonsense Mutations Associated with Reduced Levels of von Willebrand Factor Messenger RNA (1992) (60)
- Cerebral haemorrhagic infarction in young patients with hereditary protein C deficiency: evidence for "spontaneous" cerebral venous thrombosis. (1985) (60)
- Elevated Plasminogen Activator Inhibitor (PAI), a Cause of Thrombophilia? – A Study in 203 Patients with Familial or Sporadic Venous Thrombophilia (1989) (59)
- LOW-DOSE HEPARIN PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER ACUTE STROKE (1978) (57)
- Two novel point mutations correlate with an altered developmental expression of blood coagulation factor IX (hemophilia B Leyden phenotype). (1989) (56)
- A congenitally abnormal fibrinogen (Vlissingen) with a 6-base deletion in the gamma-chain gene, causing defective calcium binding and impaired fibrin polymerization. (1991) (56)
- Hemophilia B Leyden: a sex-linked hereditary disorder that improves after puberty. (1982) (56)
- Well-being of haemophilia patients: a model for direct and indirect effects of medical parameters on the physical and psychosocial functioning. (1998) (54)
- Female donors and transfusion‐related acute lung injury (2010) (52)
- Bleeding time, blood groups and von Willebrand factor (1989) (52)
- Storage time of blood products and transfusion‐related acute lung injury (2012) (46)
- Hereditary Protein C-Deficiency: Laboratory Values in Transmitters and Guidelines for the Diagnostic Procedure Report on a Study of the SSC Subcommittee on Protein C and Protein S (1992) (46)
- Carrier detection in hemophilia A: a cooperative international study. I. The carrier phenotype. (1986) (46)
- THROMBOPHILIA:ITS CAUSES AND A ROUGH ESTIMATE OF ITS PREVALENCE (1987) (45)
- A Monoclonal Antibody-Based Qunatitative Enzyme Immunoassay for the Determination of Plasma Fibrinogen Concentartions (1988) (44)
- The Increasing Prevalence of Haemophilia (1990) (44)
- High Titer Inhibitors in Severe Haemophilia A (1994) (41)
- The human clotting factor VIII cDNA contains an autonomously replicating sequence consensus- and matrix attachment region-like sequence that binds a nuclear factor, represses heterologous gene expression, and mediates the transcriptional effects of sodium butyrate (1996) (40)
- Carrier detection in hemophilia A: a cooperative international study. II. The efficacy of a universal discriminant. (1986) (38)
- Two decades of haemophilia treatment in the Netherlands, 1972–92 (1995) (38)
- A novel candidate mutation (Arg611→ His) in type I‘platelet discordant’von Willebrand's disease with desmopressin‐induced thrombocytopenia (1995) (37)
- Molecular Variant of Factor VII (1976) (37)
- Hereditary antithrombin deficiency: heterogeneity of the molecular basis and mortality in Dutch families. (1994) (37)
- Mortality after transfusions, relation to donor sex (2011) (37)
- A prospective survey of risk factors in young adults with arterial occlusive disease. (1989) (36)
- Diagnostic value of fibrinopeptide A and beta-thromboglobulin in acute deep venous thrombosis and pulmonary embolism. (2009) (36)
- Noonan syndrome: partial factor XI deficiency. (1988) (35)
- Coagulation parameters of CPD fresh‐frozen plasma and CPD cryoprecipitate‐poor plasma after storage at 4°C for 28 days (1993) (34)
- Fibrinogen Nijmegen : Congenital Dysfibrinogenemia Associated with Impaired t-PA Mediated Plasminogen Activation and Decreased Binding of t-PA (1988) (31)
- Abnormal transbilayer mobility of phosphatidylcholine in hereditary pyropoikilocytosis reflects the increased heat sensitivity of the membrane skeleton. (1985) (31)
- Evaluation of the Cuticle Bleeding Time in Canine Haemophilia A (1986) (31)
- Mesenteric vein thrombosis as presenting manifestation of hereditary protein S deficiency. (1987) (31)
- ACQUIRED VON WILLEBRAND'S DISEASE DUE TO EXCESSIVE FIBRINOLYSIS (1992) (30)
- KLINEFELTER SYNDROME: PREDISPOSITION TO ACUTE NON-LYMPHOCYTIC LEUKÆMIA? (1980) (28)
- The prophylactic treatment of hemophilia B Leyden with anabolic steroids. (1985) (28)
- Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene. (1988) (28)
- The Role of Factor VII in Haemostasis: Infusion Studies of Factor VIIa in a Canine Model of Factor VIII Deficiency (1990) (27)
- Warfarin and aspirin after heart-valve replacement. (1994) (26)
- Eleven novel mutations in the factor VIII gene from Brazilian hemophilia A patients. (1995) (26)
- A Randomized and Blinded Comparison of Three Bleeding Time Techniques: the Ivy Method, and the Simplate II® Method in Two Directions (1992) (26)
- A CRM‐Positive Variant of Factor‐VII Deficiency and the Detection of Heterozygotes with the Assay of Factor‐like Antigen (1977) (26)
- Fibrinolytic System During Long-Distance Running in IDDM Patients and in Healthy Subjects (1992) (25)
- Inhibitors in Christmas disease. (1984) (25)
- Diurnal changes in heparin effect during continuous constant‐rate infusion. A study in nine patients with venous thromboembolism (1994) (24)
- Diurnal Rhythm in Anticoagulant Effect of Heparin during a Low Dose Constant Rate Infusion (1992) (24)
- AIDS and haemophilia. A study among Dutch haemophiliacs on the psychological impact of the AIDS threat, the prevalence of HIV antibodies and the adoption of measures to prevent HIV transmission. (1988) (24)
- The role of splenectomy in the treatment of relapsing thrombotic thrombocytopenic purpura (1995) (24)
- A polymorphic Xba I site within the human von Willebrand factor (vWF) gene identified by a vWF cDNA clone. (1986) (23)
- Employment of individuals with haemophilia in The Netherlands. (1989) (22)
- A Second Plasma Inhibitor of Activated Protein C: α1-Antitrypsin (1989) (21)
- Coagulation parameters of CPD fresh-frozen plasma and CPD cryoprecipitate-poor plasma after storage at 4 degrees C for 28 days. (1993) (21)
- Combined hereditary deficiency of the sixth component of complement and factor VIII coagulant activity in a Dutch family. (1982) (21)
- Prolonged bleeding time due to mitotane therapy. (1991) (21)
- KLINEFELTER SYNDROME: PREDISPOSITION TO ACUTE NON-LYMPHOCYTIC LEUKÆMIA? (1980) (20)
- FAMILY HISTORY AND INHERITED THROMBOPHILIA (1995) (19)
- Azathioprine and subacute myelomonocytic leukemia. (2009) (19)
- Genotype Assignment of Haemophilia A by Use of Intragenic and Extragenic Restriction Fragment Length Polymorphisms (1987) (18)
- Sex ratio of the mutation frequencies in haemophilia A: coagulation assays and RFLP analysis. (1991) (18)
- State and Prospects of Gene Therapy for the Hemophilias (1995) (18)
- Hip surgery in a patient with severe factor VII deficiency. (1987) (17)
- Factor VIII preparations: need for prospective pharmacovigilance (1993) (17)
- ORAL ANTICOAGULANT DRUGS. AUTHOR'S REPLIES (1992) (17)
- Instability of repeats of the von Willebrand factor gene variable number tandem repeat sequence in intron 40 (1993) (17)
- Oral contraception and the detection of carriers in haemophilia B. (1978) (17)
- Paroxysmal Finger Haematoma: A Neglected Syndrome (1991) (16)
- Somatic origin of inherited haemophilia A (1990) (16)
- Rabbit Polyclonal Antibodies Against the Calcium-Dependent Conformation of Factor IX and Their Application in Solid Phase Immunoradiometric Assays (1986) (15)
- Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro. (1996) (15)
- Protein C (PC) and coumarin-induced skin necrosis (1986) (14)
- Sex ratio of the mutation frequencies in haemophilia A: estimation and meta-analysis (1990) (14)
- Inhibitors in hemophilia A: are some products safer? (1994) (13)
- The Clinical Diagnosis Of Deep Venous Thrombosis (1981) (13)
- PLASMA HISTIDINE-RICH GLYCOPROTEIN AND THROMBOPHILIA (1988) (13)
- A second plasma inhibitor of activated protein C: alpha 1-antitrypsin. (1989) (12)
- A one-year follow-up study of plasma fibrinopeptide A and beta-thromboglobulin after deep vein thrombosis and pulmonary embolism. (1982) (12)
- Simplified procedure for the assay of fibrinopeptide A in plasma. (1981) (12)
- The clinical benefit of blood transfusion: a hypothetical experiment based on a nationwide survey of severe maternal morbidity (2013) (12)
- Peri-Operative Replacement Therapy with Factor VII Concentrate in a Patient with Severe Factor VII Deficiency (1992) (11)
- Conservative management of placental abruption complicated by severe clotting disorders. (1992) (11)
- Plasma beta-thromboglobulin and platelet factor 4 in renal failure. (1981) (11)
- Carrier Detection of Haemophilia B by Using an Intragenic Restriction-Fragment Length Polymorphism (1985) (10)
- Double Strand Conformation Polymorphism (DSCP) Detects Two Point Mutations at Codon 280 (AAC→ATC) and at Codon 431 (TAC→AAC) of the Blood Coagulation Factor VIII Gene (1993) (10)
- First trimester prenatal diagnosis of haemophilia A: Two years' experience (1988) (10)
- Alloexposed blood donors and transfusion‐related acute lung injury: a case‐referent study (2011) (10)
- Regulation of blood coagulation and thrombosis. (1985) (10)
- The contribution of DNA analysis to carrier detection and prenatal diagnosis of hemophilia A and B (2005) (9)
- Microangiopathic haemolytic anaemia with advanced breast carcinoma: improvement with chemotherapy. (1985) (9)
- THROMBOPHILIA AND HEREDITARY INCREASE IN PLASMINOGEN ACTIVATOR INHIBITOR (PAI-1 (1988) (8)
- A solution to the problem of studying blood donor–related risk factors when patients have received multiple transfusions (2010) (8)
- The inheritance and molecular genetics of von Willebrand's disease (1995) (8)
- Two Mutations of the Factor IX Gene Including a Donor Splice Consensus Deletion and a Point Mutation in a Dutch Patient with Severe Hemophilia B (1990) (8)
- Abnormal immune parameters in HIV‐seronegative haemophilic patients (1996) (8)
- Inversions in the factor VIII gene: improvement of carrier detection and prenatal diagnosis in Dutch haemophilia A families. (1995) (8)
- Interaction of factor V Leiden with inherited anti-thrombin deficiency (1995) (6)
- Factor V Leiden mutation and contraception (1996) (6)
- Sequential administration of human and porcine factor VIII for surgical treatment of a parotid tumour in a patient with a factor VIII inhibitor. (1985) (5)
- Effects of Chronic Factor VIII Substitution on Immune Parameters in HIV Seronegative Haemophiliacs: a Comparison between Cryoprecipitate and Factor VIII Concentrate (1996) (5)
- Value of the patient interview: all but consensus among haemostasis experts. (1992) (5)
- A Dutch pedigree with mild hemophilia B with a missense mutation in the first EGF domain (factor IXOud en Nieuw Gastel). (1989) (5)
- Seeming homozygosity in type-IIB von Willebrand's disease due to a polymorphism within the sequence of a commonly used primer (1994) (5)
- Haemophilia B Leyden in Greece (1986) (5)
- A Dutch family with moderately severe hemophilia B (factor IXHeerde) has a missense mutation identical to that of factor IX London 2. (1989) (5)
- Monitoring heparin treatment with the APTT: the effect of methodological changes on the APTT. (1996) (5)
- The optimal intensity of oral anticoagulation therapy in patients with prosthetic heart valves (1992) (4)
- The clinical diagnosis of deep venous thrombosis. A study of ambulant patients in The Netherlands using Doppler ultrasonography and phlebography. (1983) (4)
- Hereditary Diseases and Blood Transfusion (1995) (4)
- The incidence of inhibitors in hemophilia A and the induction of immune tolerance. (2001) (4)
- Chronic lymphocytic leukaemia and IgG heavy chain disease. (2009) (4)
- Preparation of lyophilized heat-treated cryoprecipitates from a small pool of plasma obtained by apheresis (1991) (4)
- More objective diagnoses of venous thromboembolism? (1991) (3)
- [Revision consensus hemophilia: treatment and responsibility. Nederlandse Vereniging van Hemophilia Patients]. (1997) (3)
- Plasma Fibrinopeptide A and Beta-Thromboglobulin in Major Bacterial Infections (1982) (3)
- [Pharmacotherapeutic choices for correction of disorders of primary hemostasis]. (1999) (3)
- Three problems of hemophilia B : a study of abnormal factor IX molecules with an inhibitor neutralization assay (1977) (2)
- [Blind spots of the diagnostic hemostasis screen]. (2000) (2)
- A Study in Three Dutch Families (2018) (2)
- [Physical diagnosis--percussion and palpation of the spleen]. (2000) (2)
- [Consensus diagnosis pulmonary embolism]. (1993) (2)
- 221 Impaired stimulation of t-PA mediated plasminogen activation and decreased binding of t-PA in a congenital dysfibrinogenemia (1988) (2)
- [Recombinant factor VIIa (eptacog alfa): a new therapeutic option for patients with severe bleeding disorder due to inhibitory antibodies against a coagulation factor]. (1998) (2)
- Variants of Vitamin K Dependent Coagulation Factors (1979) (2)
- [Consensus hemophilia treatment]. (1987) (2)
- Partial Reconstitution of Factor VIII Activity from a Mild Crm+ Hemophilia A Patient by Replacement of the Defective A2 Domain (1998) (2)
- [Prevention of central nervous system hemorrhages in patients with hemophilia]. (1992) (1)
- Thyroxine supplementation in very preterm infants (1998) (1)
- THE ORIGIN OF THE MUTATION IN FAMILIES WITH AN ISOLATED CASE OF HAEMOPHILIA A (1987) (1)
- [The causes of venous thrombosis and lung embolism]. (1985) (1)
- Quality control programme for the preparation of small-pool lyophilized heat-treated cryoprecipitates (1991) (1)
- [Detection of carrier state of hemophilia; current status]. (1984) (1)
- Low-dose subcutaneous heparin for prevention of deep vein thrombosis in non-surgical patients. (1985) (1)
- Allo‐exposure status and leucocyte antibody positivity of blood donors show a similar relation with TRALI (2012) (1)
- Tolerance and intolerance to factor VIII: a clinical perspective. (1995) (1)
- Carrier Detection in Hemophilia B. (1977) (1)
- Fibrinopeptide A And Beta-Thromboglobulin Concentrations In Venous And Arterial Disorders (1981) (1)
- TWO VON WILLEBRAND FACTOR (vWF) GENE POLYMORPHISMS SEGREGATE WITH VON WILLEBRAND'S DISEASE (vWD) TYPE IIA: ASSIGNMENT OF THE DEFECTIVE GENE LOCUS IN vWD TYPE IIA (1987) (1)
- Abnormal fibrins defective in the exposure of sites involved in the acceleration of t-PA mediated plasminogen activation (1994) (1)
- Thrombosis, anticoagulation and bleeding: About age and other risk factors (1992) (0)
- [Search for the carrier state of hemophilia B using restriction fragment length polymorphism]. (1985) (0)
- A 72-year-old woman with fever and diffuse intravascular coagulation (1992) (0)
- Coagulum pyelolithotomy: the determination of optimal conditions for clot formation (1986) (0)
- Toward Gene Therapy in Hemophilia A: Introduction of Factor VIII Expression Vectors Into Somatic Cells (1990) (0)
- L.E.T.S.: Leiden thrombophilia study; interim analysis (1992) (0)
- [Oral contraception increases the chance of venous thrombosis in factor V Leiden mutation]. (1995) (0)
- Oral anticoagulant drugs. (1992) (0)
- [HIV infection in hemophilia patients; report from the National Ombudsman]. (1995) (0)
- X-Linked Coagulation Disorders (1984) (0)
- IMMUNOLOGICAL ASSAYS FOR THE Ca(II)-DEPENDENT AND NONCa(II)-DEPENDENT CONFORMATIONS OFJtLUMAN PROTELN Z (PZ) (1987) (0)
- [Epidemiology of AIDS and HIV infections in the Netherlands; current status and prognosis for 1987-1990]. (1987) (0)
- Hereditary protein C deficiency in symptomatic families: Individuals with the genetic defect have an increased risk for venous thrombotic events (1992) (0)
- [Positive effect of long-term coumarin treatment following a heart infarct]. (1994) (0)
- [Social effects of current hemophilia treatment]. (1989) (0)
- Circadian changes in heparin sensitivity (1990) (0)
- Thrombosis in Families With Inherited Antithrombin Deficiency Gene-Gene and Gene-Environment Interactions Determine Risk of (2013) (0)
- [Doubts about the new oral anticoagulants]. (2014) (0)
- [Hemorrhagic diathesis in Noonan syndrome]. (1987) (0)
- [Abruptio placentae and coagulation disorders]. (1991) (0)
- O764 THE CLINICAL BENEFIT OF BLOOD TRANSFUSION; A HYPOTHETICAL EXPERIMENT BASED ON A NATIONWIDE SURVEY OF SEVERE MATERNAL MORBIDITY (2012) (0)
- No Malabsorption of Inorganic Ferrous Iron in Patients with Achylia gastrica (1979) (0)
- Inversions inthefactor VIIIgene: improvement ofcarrier detection andprenatal diagnosis in Dutchhaemophilia A families (1995) (0)
- Use of Gene Probes for Carrier Detection and Prenatal Diagnosis in Hemophilia A (1988) (0)
- A Molecular Variant of Factor VII. Correction (1977) (0)
- Renal embolisation in Glanzmann's thrombasthenia. (1980) (0)
- Lover's arm (1992) (0)
- Research and development (2010) (0)
- In Vitro Determination of Optimal Conditions for Coagulum Pyelolithotomy (1985) (0)
- Thrombosis-related death in families with inherited antithrombin deficiency (1996) (0)
- phenotype) expression of blood coagulation factor IX (hemophilia B Leyden Two novel point mutations correlate with an altered developmental (2011) (0)
- [An unusual cause of hemorrhagic diathesis]. (1981) (0)
- THE BENEFITS OF MODERN SUBSTITUTION THERAPY IN HEMOPHILIA (1987) (0)
- The Molecular Defect Of Factor IX Chapel Hill (1981) (0)
- Royal academy of medicine in Ireland international conference on homocysteine metabolism from basic science to clinical medicine (1995) (0)
- Heparin treatment: confusion still prevails. (1989) (0)
- [Are there still indications for plasma transfusions?]. (1991) (0)
- [The yet unexpected vitamin K deficiency]. (1986) (0)
- Hereditary diseases and blood transfusion : proceedings of the Nineteenth International Symposium on Blood Transfusion, Groningen, 1994 (1995) (0)
- ALLO-EXPOSED BLOOD DONORS AND TRANSFUSION-RELATED ACUTE LUNG INJURY (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ernest Briët?
Ernest Briët is affiliated with the following schools:
